Abiopharma

News list

(99% Neutral) ChemoCentryx, Inc. (CCXI) Announces Business Combination

Full text

News bot Oct. 3, 2025, 9:26 a.m.
📋 ChemoCentryx, Inc. (CCXI) - Business Combination

Filing Date: 2022-10-18

Accepted: 2022-10-18 16:16:39

Event Type: Business Combination
Event Details:
ChemoCentryx Inc (the company became a subdivision of the company Amgen (NASDAQ: AMGN)) (CCXI) Announces Business Combination ChemoCentryx Inc (the company became a subdivision of the company Amgen (NASDAQ: AMGN)) (CCXI) has entered into a strategic transaction. Transaction Details:
Company has entered into an acquisition agreement.
💼 Business Developments:
- Partnership
- Acquisition
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: ChemoCentryx Inc (the company became a subdivision of the company Amgen (NASDAQ: AMGN))
- CIK: 0001340652
- Ticker Symbol: CCXI
- Period End Date: 2022-10-18
- Document Type: 8-K